2021
DOI: 10.3390/jcm10215040
|View full text |Cite
|
Sign up to set email alerts
|

Special Issue Recurrent Pregnancy Loss: Etiology, Diagnosis, and Therapy

Abstract: The definition of recurrent pregnancy losses (RPL) varies between guidelines from different national and international scientific societies, but overall, a history of two or more (or alternatively, three or more) confirmed pregnancy losses is required for the diagnosis [...]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0
2

Year Published

2022
2022
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 10 publications
0
8
0
2
Order By: Relevance
“…Це дозволить покращити прогноз вагітності, знизити рівень перинатальної патології, що буде мати вагомий медико-соціальний ефект. Christiansen OB(2021) [25]; Torchinov AM(2017) [26]; Khobotna IM (2021) [28]; Garrido-Gimenez C(2015) [17];…”
Section: висновкиunclassified
See 1 more Smart Citation
“…Це дозволить покращити прогноз вагітності, знизити рівень перинатальної патології, що буде мати вагомий медико-соціальний ефект. Christiansen OB(2021) [25]; Torchinov AM(2017) [26]; Khobotna IM (2021) [28]; Garrido-Gimenez C(2015) [17];…”
Section: висновкиunclassified
“…Відомо, що в структурі причин перинатальних втрат одне з провідних місць займають екстрагенітальні захворювання жінки. У 60% жінок екстрагенітальна патологія є причиною акушерських ускладнень, в самовільних викиднів утому числі [17,18,25,26,27,28,29].…”
unclassified
“…D u e t o a n i n s u f f i c i e n t u n d e r s t a n d i n g o f t h e pathogenesis of RPL and UI, treatment is challenging. The pathogenesis of RPL and UI is multifactorial, and recurring fetal chromosomal abnormalities, the presence of antiphospholipid antibodies, and clinical thyroid disorders are considered risk factors for RPL and UI (8,9). However, the endometrium is a critical factor in RPL and UI because it receives embryos (10,11).…”
Section: Introductionmentioning
confidence: 99%
“…Chromosomal abnormalities in the woman or her partner, congenital or acquired anatomical factors, endocrinopathies, and antiphospholipid syndrome (APS) should be included in the initial diagnostic work‐up of couples with RM. The investigation of autoimmune and alloimmune factors in RM is not recommended by the ESHRE Guideline despite robust evidence of the association between immune disorders and the risk of pregnancy loss 13,14 …”
Section: Introductionmentioning
confidence: 99%